Rescue medications + Sacituzumab tirumotecan for endometrial neoplasms

A treatment and a condition, followed through the public trial records. Not medical advice. How a status is set

Phase 3 trial. Large late-stage trial in people. As of 19 Nov 2026, from 1 registered trial.

Why this status

  1. 15 Nov 2023: Trial registered, NCT06132958
  2. 6 Dec 2023: Trial started, NCT06132958

The trials

NCT06132958: Sacituzumab Tirumotecan (MK-2870) in Post Platinum and Post Immunotherapy Endometrial Cancer (MK-2870-005)

State
Under way
Phase
Phase 3
People
710 planned
Started
6 Dec 2023
Primary completion
10 Jan 2028
Arms
Sacituzumab tirumotecan
Results
None posted
  1. 15 Nov 2023: Trial registered
  2. 6 Dec 2023: Trial started

How the status changed

  1. 19 Nov 2026: First set: Phase 3 trial

Registries searched: ClinicalTrials.gov, through 17 Nov 2026.